Strategic Diagnostics Inc. Becomes SDIX

NEWARK, Del.–Strategic Diagnostics Inc., a provider of biotechnology-based products and services for a broad range of life science, biotechnology, diagnostic, and food safety applications, has announced it will be doing business as SDIX (Strategic Diagnostics Inc. d/b/a SDIX).

The new SDIX name and logo are designed to better reflect the company’s evolution from its historical beginnings as an industrial diagnostics products and antibody production company to the company it is today, a biotechnology company, with all of its core capabilities and expanded expertise in developing and delivering a full suite of innovative immuno-solutions. The new name also aligns the company name with its website address and NASDAQ listing, making the company easier to find and connect to.

Commenting on the announcement, Mr. Fran DiNuzzo, President and CEO of SDIX said, “Over the last twenty years, Strategic Diagnostics Inc. has grown by delivering value and innovation to our customers. Over the past several years, the company has emerged as an innovative supplier of immuno-solutions to new customers in the Life Science market. As such, the company has evolved beyond its name and brand.

Today, our company is much more than the original Strategic Diagnostics name or SDI logo represented.  We are transforming SDI into a biotechnology company with a key focus on growth in the Life Science and Food Safety markets. We intend for SDIX and our updated logo to symbolize our commitment to be experts at creating advantage for our customers and partners using quality, innovative, and effective immuno-solutions.”